MedTrace Logo

Acupressure and Stress Resilience

NCT01614444 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-05-19

No results posted yet for this study

Summary

The current study will assess the efficacy of acupressure, a type of complementary and alternative medicine (CAM) in the Veteran population. Veterans with co-occurring mild traumatic brain injury (mTBI) and post-traumatic stress disorder (PTSD) will be consented and randomly assigned to either an active or placebo acupressure treatment series of 8 sessions. The investigators will determine if acupressure affects aspects of day-to-day function, such as memory, sleep, mood, psychiatric health and stress resilience. This information will help identify potential treatment strategies to improve quality of life and overall function in this particular Veteran population.

Conditions

  • Post-traumatic Stress Disorder (PTSD)
  • Mild Traumatic Brain Injury (mTBI)

Interventions

OTHER

Active Acupressure Treatment

Participant will receive 8 active acupressure treatments.

OTHER

Placebo Acupressure Treatment

Participants will receive 8 placebo acupressure treatments.

Sponsors & Collaborators

  • University of Colorado, Boulder

    collaborator OTHER

  • United States Department of Defense

    collaborator FED

  • VA Eastern Colorado Health Care System

    lead FED

Principal Investigators

  • Theresa D Hernandez, Ph.D. · Senior Investigator and Research Psychologist Eastern Colorado Healthcare System, VISN19, MIRECC

  • Lisa A Brenner, Ph.D. · Eastern Colorado Healthcare System VISN 19 MIRECC Director

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-13
Primary Completion
2014-08-11
Completion
2017-03-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01614444 on ClinicalTrials.gov